ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Acquiring determined the palmitoylation motif of APLNR, we made a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation internet site in combination with morphine, can inhibit the development of NCP, which includes pain incidence, microglial activati